@inproceedings{inproceedings, title = {{MO2 - MODELLING OVERALL SURVIVAL IN IMMUNOTHERAPY USING PARAMETRIC TECHNIQUES: AVELUMAB IN PREVIOUSLY TREATED METASTATIC MERKEL CELL CARCINOMA}}, publisher = {{Elsevier BV}}, url = {{}}, year = {{2018}}, month = {{10}}, author = {{Bullement A and Amin A and Stapelkamp C and Willis A and Lilley C and Hatswell AJ and Pescott C and Bharmal M}}, doi = {{10.1016/j.jval.2018.09.062}}, volume = {{21}}, journal = {{Value in Health}}, pages = {{S11-S11}}, note = {{Accessed on 2025/07/08}}}